Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Bernhard J. Eigl"'
Autor:
Nicolette M. Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Andrew J. Murtha, Catarina Kollmannsberger, Edmond M. Kwan, Karan Parekh, Elena Schönlau, Cecily Q. Bernales, Gráinne Donnellan, Sarah W. S. Ng, Takayuki Sumiyoshi, Joanna Vergidis, Krista Noonan, Daygen L. Finch, Muhammad Zulfiqar, Stacy Miller, Sunil Parimi, Jean-Michel Lavoie, Edward Hardy, Maryam Soleimani, Lucia Nappi, Bernhard J. Eigl, Christian Kollmannsberger, Sinja Taavitsainen, Matti Nykter, Sofie H. Tolmeijer, Emmy Boerrigter, Niven Mehra, Nielka P. van Erp, Bram De Laere, Johan Lindberg, Henrik Grönberg, Daniel J. Khalaf, Matti Annala, Kim N. Chi, Alexander W. Wyatt
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract No consensus strategies exist for prognosticating metastatic castration-resistant prostate cancer (mCRPC). Circulating tumor DNA fraction (ctDNA%) is increasingly reported by commercial and laboratory tests but its utility for risk stratific
Externí odkaz:
https://doaj.org/article/6914ec1e3ba942ee99b1463117270db9
Autor:
Feras A. Moria, Changsu L. Park, Bernhard J. Eigl, Robyn Macfarlane, Michel Pavic, Ramy R. Saleh
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 704-722 (2024)
Locally advanced or metastatic urothelial carcinoma (aUC) presents a significant challenge with high mortality rates. Platinum-based chemotherapy remains the established frontline standard of care, and a switch-maintenance strategy with immunotherapy
Externí odkaz:
https://doaj.org/article/3f304287e7bd48d488811d2078269278
Autor:
Neil E. Fleshner, Shabbir M. H. Alibhai, Kim A. Connelly, Ilidio Martins, Bernhard J. Eigl, Himu Lukka, Armen Aprikian
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Orally administrated agents play a key role in the management of prostate cancer, providing a convenient and cost-effective treatment option for patients. However, they are also associated with adherence issues which can compromise therap
Externí odkaz:
https://doaj.org/article/e142286d478b4810b1800c8de4573e50
Autor:
Stephen Sundquist, Gerald Batist, Kathy Brodeur-Robb, Kathryn Dyck, Bernhard J. Eigl, David K. Lee, Jaqueline Limoges, Holly Longstaff, Jim Pankovich, Anna Sadura, Patrick Sullivan, Janet E. Dancey
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3857-3865 (2021)
Canada’s vast geography, and centralized delivery of cancer care and clinical trials create barriers for trial participation for patients in remote and rural settings. The development and implementation of a framework that enables safe and regulato
Externí odkaz:
https://doaj.org/article/8a1ef9f8529040d5a5f614026d3da060
Autor:
Jean-Michel Lavoie, Priya Baichoo, Elizabeth Chavez, Lucia Nappi, Daniel Khalaf, Christian K. Kollmannsberger, Kim N. Chi, Andrew Weng, Christian Steidl, Bernhard J. Eigl, Michael Nissen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Immune checkpoint inhibitors (ICI) are used in the treatment of urothelial and renal cell cancers. While some patients may have exceptional responses, better predictive biomarkers are needed. We profiled the circulating immune compartment of patients
Externí odkaz:
https://doaj.org/article/5516a4945ece4cb4acf0697755e5726b
Autor:
Gillian Vandekerkhove, Jean-Michel Lavoie, Matti Annala, Andrew J. Murtha, Nora Sundahl, Simon Walz, Takeshi Sano, Sinja Taavitsainen, Elie Ritch, Ladan Fazli, Antonio Hurtado-Coll, Gang Wang, Matti Nykter, Peter C. Black, Tilman Todenhöfer, Piet Ost, Ewan A. Gibb, Kim N. Chi, Bernhard J. Eigl, Alexander W. Wyatt
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
In metastatic urothelial carcinoma, it has not been established whether circulating tumor DNA (ctDNA) can replace archival primary tissue to assess mutations and biomarkers. Here, the authors show high mutation concordance between ctDNA and tumour ti
Externí odkaz:
https://doaj.org/article/a2f42ea8d98a4db587379bb0ba66d3fe
Autor:
Jean-Michel Lavoie, Gillian Vandekerkhove, Andrew J. Murtha, Gang Wang, Alexander W. Wyatt, Bernhard J. Eigl
Publikováno v:
Urology Case Reports, Vol 39, Iss , Pp 101762- (2021)
The management of metastatic urothelial cancer is rapidly evolving since immune checkpoint inhibitors were introduced. We present the case of a patient with metastatic upper tract urothelial cancer who had a complete response to durvalumab and tremel
Externí odkaz:
https://doaj.org/article/ff2ebdbc93ad43f0bb25309772f79d18
Autor:
Carlo Buonerba, Giuseppe Di Lorenzo, Gregory Pond, Giacomo Cartenì, Sarah Scagliarini, Antonio Rozzi, Fernando J Quevedo, Tanya Dorff, Lucia Nappi, Gaetano Lanzetta, Lance Pagliaro, Bernhard J. Eigl, Gurudatta Naik, Matteo Ferro, Sabino De Placido, Guru Sonpavde
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
AbstractIntroduction & objectives: Metastatic penile squamous cell carcinoma (PSCC) is associated with dismal outcomes with median overall survival (OS) of 6-12 months in the first-line and
Externí odkaz:
https://doaj.org/article/6eb7f95a51ca4ac0ab07710596c6f501
Autor:
François Bénard, Sara Harsini, Don Wilson, Katherine Zukotynski, Gad Abikhzer, Eric Turcotte, Mariève Cossette, Ur Metser, Jonathan Romsa, Montgomery Martin, Colin Mar, Fred Saad, Jean-Paul Soucy, Bernhard J Eigl, Peter Black, Andra Krauze, Steven Burrell, Alan Nichol, Jean-Claude Tardif
Publikováno v:
The Lancet Oncology. 23:1499-1507
Autor:
Kim N. Chi, Alexander W. Wyatt, Martin E. Gleave, Matti Nykter, Arun A. Azad, Muhammad Zulfiqar, Joanna Vergidis, Conrad D. Oja, Daygen Finch, Bernhard J. Eigl, Christian Kollmannsberger, Katherine Sunderland, Evan W. Warner, Kevin Beja, Sinja Taavitsainen, Daniel Khalaf, Gillian Vandekerkhove, Matti Annala
Supplementary Tables S1 - S9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3817d8a283a1763bf881666a0afc30a0
https://doi.org/10.1158/2159-8290.22533116
https://doi.org/10.1158/2159-8290.22533116